FinTrust Capital Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$115K Buy
1,368
+14
+1% +$1.07K 0.02% 399
2024
Q2
$92.9K Buy
1,354
+34
+3% +$2.27K 0.02% 413
2024
Q1
$96.7K Buy
1,320
+634
+92% +$48.8K 0.02% 395
2023
Q4
$55.6K Hold
686
0.01% 463
2023
Q3
$51.4K Sell
686
-243
-26% -$18.7K 0.01% 448
2023
Q2
$79.8K Hold
929
0.02% 380
2023
Q1
$79.8K Hold
929
0.02% 378
2022
Q4
$79.8K Hold
929
0.02% 378
2022
Q3
$62K Sell
929
-230
-20% -$14.5K 0.02% 467
2022
Q2
$70K Sell
1,159
-83
-7% -$5.14K 0.02% 466
2022
Q1
$74K Hold
1,242
0.02% 478
2021
Q4
$90K Sell
1,242
-651
-34% -$44.8K 0.02% 447
2021
Q3
$132K Sell
1,893
-377
-17% -$26.5K 0.03% 353
2021
Q2
$156K Buy
2,270
+470
+26% +$31.4K 0.04% 327
2021
Q1
$116K Sell
1,800
-710
-28% -$45.8K 0.03% 376
2020
Q4
$146K Sell
2,510
-2,927
-54% -$177K 0.05% 302
2020
Q3
$344 Sell
5,437
-14,829
-73% -$1.03M 0.07% 157
2020
Q2
$1.56M Buy
20,266
+16,644
+460% +$1.28M 0.62% 45
2020
Q1
$271K Buy
3,622
+2,162
+148% +$149K 0.13% 144
2019
Q4
$95K Buy
1,460
+400
+38% +$26K 0.04% 332
2019
Q3
$67K Sell
1,060
-1,828
-63% -$119K 0.02% 399
2019
Q2
$195K Sell
2,888
-229
-7% -$15.1K 0.08% 192
2019
Q1
$203K Buy
3,117
+32
+1% +$2.13K 0.09% 183
2018
Q4
$193K Buy
+3,085
New +$216K 0.1% 180

Other funds holding GILD

FinTrust Capital Advisors's GILD Position: Q3 2024 in Review

FinTrust Capital Advisors increased its Gilead Sciences (GILD) stake by 1% in Q3 2024, buying an estimated $1.07K and bringing the position to 1,368 shares worth $115K. The position accounts for 0.02% of the portfolio, ranked #399.

FinTrust Capital Advisors first reported a position in GILD in Q4 2018 and has held it in 24 quarters since. The position peaked at $1.56M in Q2 2020. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • FinTrust Capital Advisors held 1,368 shares of Gilead Sciences worth $115K as of Q3 2024.
  • FinTrust Capital Advisors bought 14 Gilead Sciences shares in Q3 2024, an estimated $1.07K.
  • Gilead Sciences made up 0.02% of FinTrust Capital Advisors's portfolio in Q3 2024, its #399 holding.
  • FinTrust Capital Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 24 quarters since.
  • FinTrust Capital Advisors's Gilead Sciences position peaked at $1.56M in Q2 2020.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.